Paper22326218
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
Yuneva MO and 11 others. Cell Metab, 2012. Cited by 561 papers, by iCite.
Cite this record
ConductScience Library. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Papers, record 22326218. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22326218
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Lung Neoplasms | Major topic |
| Metabolome | Major topic |
| Proto-Oncogene Proteins c-met | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Animals | |
| Blotting, Western | |
| Cell Line, Tumor | |
| Citric Acid Cycle | |
| DNA Primers | |
| Glucokinase | |
| Glucose | |
| Glutamine | |
| Humans | |
| Immunoblotting | |
| Immunohistochemistry | |
| Isotope Labeling | |
| Lactic Acid | |
| Mice | |
| Nuclear Magnetic Resonance, Biomolecular | |
| RNA Interference |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P20RR018733 | NCRR NIH HHS | United States | P20RR018733 | PubMed and NIH | NIH RePORTER |
| R21 NS074151 | NINDS NIH HHS | United States | R21NS074151 | PubMed and NIH | NIH RePORTER |
| 1R01CA118434-01A2 | NCI NIH HHS | United States | R01CA118434 | PubMed and NIH | NIH RePORTER |
| 3R01 CA118434-02S1 | NCI NIH HHS | United States | R01CA118434 | PubMed and NIH | NIH RePORTER |
| P20 RR018733 | NCRR NIH HHS | United States | P20RR018733 | PubMed and NIH | NIH RePORTER |
| R35 CA044338 | NCI NIH HHS | United States | R35CA044338 | PubMed and NIH | NIH RePORTER |
| R21NS074151 | NINDS NIH HHS | United States | R21NS074151 | PubMed and NIH | NIH RePORTER |
| R01 CA118434 | NCI NIH HHS | United States | R01CA118434 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02938546 | 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study | Results |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 22326214 | METabolic adaptations in the tumor MYCroenvironment. | https://conductscience.org/library/papers/22326214 |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8527215 | Regulation of glutaminase activity and glutamine metabolism. | Annu Rev Nutr | 1995 | https://conductscience.org/library/papers/8527215 | PubMed |
| 2 | 10776894 | An enzymatic approach to lactate production in human skeletal muscle during exercise. | Med Sci Sports Exerc | 2000 | https://conductscience.org/library/papers/10776894 | PubMed |
| 3 | 15516961 | Why do cancers have high aerobic glycolysis? | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15516961 | PubMed |
| 4 | 11170292 | Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. | Genes Chromosomes Cancer | 2001 | https://conductscience.org/library/papers/11170292 | PubMed |
| 5 | 21555572 | Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21555572 | PubMed |
| 6 | 18066065 | Widespread microRNA repression by Myc contributes to tumorigenesis. | Nat Genet | 2008 | https://conductscience.org/library/papers/18066065 | PubMed |
| 7 | 16720383 | Pathways from glutamine to apoptosis. | Front Biosci | 2006 | https://conductscience.org/library/papers/16720383 | PubMed |
| 8 | 21666826 | Stable isotope resolved metabolomics of lung cancer in a SCID mouse model. | Metabolomics | 2011 | https://conductscience.org/library/papers/21666826 | PubMed |
| 9 | 12447692 | New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. | Oncogene | 2002 | https://conductscience.org/library/papers/12447692 | PubMed |
| 10 | 16741310 | Impact of animal handling on the results of 18F-FDG PET studies in mice. | J Nucl Med | 2006 | https://conductscience.org/library/papers/16741310 | PubMed |
| 11 | 19881548 | Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. | Oncogene | 2010 | https://conductscience.org/library/papers/19881548 | PubMed |
| 12 | 16640561 | Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase. | FEBS J | 2006 | https://conductscience.org/library/papers/16640561 | PubMed |
| 13 | 19029958 | Reflecting on 25 years with MYC. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/19029958 | PubMed |
| 14 | 10823814 | Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10823814 | PubMed |
| 15 | 6751566 | Glycolysis, glutaminolysis and cell proliferation. | Cell Biol Int Rep | 1982 | https://conductscience.org/library/papers/6751566 | PubMed |
| 16 | 17596215 | Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase. | J Neurochem | 2007 | https://conductscience.org/library/papers/17596215 | PubMed |
| 17 | 16036222 | Isolated mouse liver mitochondria are devoid of glucokinase. | Biochem Biophys Res Commun | 2005 | https://conductscience.org/library/papers/16036222 | PubMed |
| 18 | 11005571 | HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells. | Neoplasia | 2000 | https://conductscience.org/library/papers/11005571 | PubMed |
| 19 | 11085998 | Caspases disrupt the nuclear-cytoplasmic barrier. | J Cell Biol | 2000 | https://conductscience.org/library/papers/11085998 | PubMed |
| 20 | 18177721 | The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. | Cell Metab | 2008 | https://conductscience.org/library/papers/18177721 | PubMed |
Cited by427
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 561 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42524611 | Exploring Lipid Metabolic Reprogramming: Mechanistic Insights and Implications for Tumor Radiotherapy. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42524611 | PubMed |
| 42514928 | 70 Years of DON and Beyond: Glutaminase Inhibition as a Synergistic Strategy in Cancer Combination Therapy. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514928 | PubMed |
| 42412619 | Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis. | Cancer Res | 2026 | https://conductscience.org/library/papers/42412619 | PubMed |
| 42092914 | Association of serum lactate and one-year mortality among women with coronary artery bypass grafting surgery: filling gaps in female. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42092914 | PubMed |
| 41856993 | Vaccinia-related kinase 2 inhibition elicits vulnerability of glutathione metabolism in pancreatic cancer. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41856993 | PubMed |
| 41849351 | Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer. | Cell Rep | 2026 | https://conductscience.org/library/papers/41849351 | PubMed |
| 41792266 | The lncRNA DAMER selectively guides m6A-dependent regulation of ATF4 and asparagine metabolism under nutrient stress in cancer. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/41792266 | PubMed |
| 41663272 | Metabolic permissiveness: how tissue context shapes cancer. | Genes Dev | 2026 | https://conductscience.org/library/papers/41663272 | PubMed |
| 41512056 | Impaired nitrogenous waste clearance promotes hepatocellular carcinoma. | Sci Adv | 2026 | https://conductscience.org/library/papers/41512056 | PubMed |
| 41437070 | Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41437070 | PubMed |
| 41219185 | Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status. | Nat Commun | 2025 | https://conductscience.org/library/papers/41219185 | PubMed |
| 41213925 | Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41213925 | PubMed |
| 41123823 | Amino acid metabolism-related LncRNAs as prognostic biomarkers and predictors of immunotherapy response in hepatocellular carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41123823 | PubMed |
| 41082401 | Zonation, Zonation, Zonation: The Real Estate of the Liver. | Annu Rev Pathol | 2026 | https://conductscience.org/library/papers/41082401 | PubMed |
| 40801609 | Oxidative and Glycolytic Metabolism: Their Reciprocal Regulation and Dysregulation in Cancer. | Cells | 2025 | https://conductscience.org/library/papers/40801609 | PubMed |
| 40720255 | Metabolic adaptations in cancer progression. | Physiol Rev | 2026 | https://conductscience.org/library/papers/40720255 | PubMed |
| 40703527 | The lactylation-macrophage interplay: implications for gastrointestinal disease therapeutics. | Front Immunol | 2025 | https://conductscience.org/library/papers/40703527 | PubMed |
| 40567251 | Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40567251 | PubMed |
| 40563292 | Decoding the NRF2-NOTCH Crosstalk in Lung Cancer-An Update. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40563292 | PubMed |
| 40550888 | The metabolic shift of glutaminase 2 to glutaminase 1 promotes LGR5 + progenitor cell proliferation in liver cirrhosis. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40550888 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22326218
GET https://conductscience.org/api/papers/v1/22326218/references?page=2